Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy
Submitted by
admin
on February 20, 2018 - 10:58pm
Source:
Xconomy
News Tags:
AbbVie
Voyager Therapeutics
gene therapy
Alzheimer's disease
Headline:
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy
Do Not Allow Advertisers to Use My Personal information
